BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 05, 2011
 |  BC Week In Review  |  Company News  |  Other News

Aveva Drug Delivery Systems, BioDelivery, MonoSol Rx, Meda drug delivery, neurology news

The U.S. Patent & Trademark Office (PTO) rejected all claims of MonoSol's U.S. Patent No. 7,824,588 covering methods of making drug-containing films. BioDelivery requested PTO to reexamine the claims in the '588 patent in September. MonoSol filed suit last November in the U.S. District Court for the...

Read the full 212 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >